Mivebresib (ABBV-075) 是一种新型的 BET family bromodomain 抑制剂。以相似的亲和力结合BRD2/4/T的溴区(Ki值在1-2.2 nM间),具有高度选择性。对BRD3的效力比较低(Ki=12.2 nM),对CREBBP具有中等活性(Ki=87 μM)。Mivebresib(ABBV-075) 可有效地触发多种肿瘤细胞的凋亡。
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
Mivebresib
CAS number:1445993-26-9 molecular formula:C22H19F2N3O4S
overview
compound introduction
Specs
| Chinese alias | - | ||
| English alias | Mivebresib [USAN] | Mivebresib; ABBV-075 | Mivebresib | SCHEMBL15068241 | AKOS030628486 | N-[4-(2,4-difluorophenoxy)-3-(6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl]ethanesulfonamide | N-[4-(2,4-difluorophenoxy)-3-{6-methyl-7-oxo-1H,6H,7H-pyrrolo[2 | ||
| CAS number | 1445993-26-9 | molecular formula | C22H19F2N3O4S |
| molecular weight | 459.47 g/mol | Exact mass | - |
| PSA | 99.900 Ų | logp | 2.900 |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS





